This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

OSC Investor Alert - Emerging World Pharma, Inc.

TORONTO, Dec. 12, 2012 /CNW/ - The Ontario Securities Commission (OSC) is warning Ontario investors to exercise caution in any dealings with representatives of Emerging World Pharma, Inc. ("Emerging World").

While Emerging World represents itself to be headquartered in Sunyani, Ghana, its officers and director are residents of Ontario and its shares were traded on the over-the-counter market in the United States.

On December 6, 2012, the U.S. Securities and Exchange Commission (SEC) suspended trading in the shares of Emerging World , noting that "questions have arisen concerning the adequacy and accuracy of press releases and other public statements concerning Emerging World's business operation and financial condition."

Trading in the shares of Emerging World has been suspended for a period of 10 days, ending at 11:59 p.m. EST on December 19, 2012.

The mandate of the OSC is to provide protection to investors from unfair, improper or fraudulent practices and to foster fair and efficient capital markets and confidence in capital markets. Investors are urged to check the registration of any person or company offering an investment opportunity and to review the OSC's investor materials available at www.osc.gov.on.ca

If you have any questions or information relating to this matter, please contact the OSC Contact Centre at 1-877-785-1555.

SOURCE Ontario Securities Commission
Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,553.98 -89.03 -0.53%
S&P 500 1,978.35 -10.52 -0.53%
NASDAQ 4,806.3490 -21.9760 -0.46%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs